Investors bought shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading on Tuesday. $102.57 million flowed into the stock on the tick-up and $87.15 million flowed out of the stock on the tick-down, for a money net flow of $15.42 million into the stock. Of all equities tracked, UnitedHealth Group had the 18th highest net in-flow for the day. UnitedHealth Group traded down ($0.46) for the day and closed at $139.86

A number of equities analysts have recently issued reports on UNH shares. Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Morgan Stanley reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Jefferies Group reiterated a “buy” rating and set a $153.00 target price on shares of UnitedHealth Group in a research report on Tuesday, May 17th. FBR & Co reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, April 20th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $146.00 target price on the stock in a research report on Wednesday, April 20th. Two equities research analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $146.02.

The company has a 50-day moving average of $138.08 and a 200 day moving average of $126.55. The firm has a market capitalization of $132.98 billion and a price-to-earnings ratio of 22.49.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 19th. The healthcare conglomerate reported $1.81 EPS for the quarter, topping the consensus estimate of $1.72 by $0.09. During the same quarter in the prior year, the business earned $1.46 earnings per share. The business had revenue of $44.50 billion for the quarter, compared to analyst estimates of $43.96 billion. The firm’s quarterly revenue was up 24.5% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Inc. will post $7.89 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Stockholders of record on Friday, June 17th were given a $0.625 dividend. The ex-dividend date was Wednesday, June 15th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.79%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.50.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 20th. The shares were sold at an average price of $134.87, for a total value of $674,350.00. Following the transaction, the director now owns 73,229 shares in the company, valued at approximately $9,876,395.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,500 shares of the business’s stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $139.80, for a total transaction of $768,900.00. Following the completion of the transaction, the director now owns 59,019 shares in the company, valued at approximately $8,250,856.20. The disclosure for this sale can be found here.

Several hedge funds recently added to or reduced their stakes in UNH. Mizuho Trust & Banking Co. Ltd. raised its stake in UnitedHealth Group by 1.5% in the fourth quarter. Mizuho Trust & Banking Co. Ltd. now owns 1,444,382 shares of the healthcare conglomerate’s stock valued at $171,766,000 after buying an additional 20,971 shares in the last quarter. Sawgrass Asset Management LLC raised its stake in UnitedHealth Group by 124.4% in the fourth quarter. Sawgrass Asset Management LLC now owns 330,357 shares of the healthcare conglomerate’s stock valued at $38,863,000 after buying an additional 183,157 shares in the last quarter. Oppenheimer & Co. Inc. raised its stake in UnitedHealth Group by 189.2% in the fourth quarter. Oppenheimer & Co. Inc. now owns 76,706 shares of the healthcare conglomerate’s stock valued at $9,024,000 after buying an additional 50,183 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in UnitedHealth Group by 1.6% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 62,272 shares of the healthcare conglomerate’s stock valued at $7,326,000 after buying an additional 1,005 shares in the last quarter. Finally, Penobscot Investment Management Company Inc. raised its stake in UnitedHealth Group by 52.5% in the fourth quarter. Penobscot Investment Management Company Inc. now owns 8,603 shares of the healthcare conglomerate’s stock valued at $1,012,000 after buying an additional 2,960 shares in the last quarter.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.